1. 684PAn exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for peritoneal disseminated gastric cancer patients with inadequate oral intake. (23rd October 2018) Authors: Kadowaki, S; Ishigami, H; Muro, K; Yoshida, S; Hirono, Y; Tomita, T; Yabusaki, H; Kusumoto, T; Ota, M; Kodera, Y; Tsuji, Y; Hidemura, A; Hachiya, O; Oba, K; Kitayama, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Black oesophagus—cause?. Issue 2 (11th January 2005) Authors: Sako, A; Kitayama, J; Inoue, T; Kaizaki, S; Nagawa, H; Suzuki, H Journal: Gut Issue: Volume 54:Issue 2(2005) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis. Issue 13 (7th July 2020) Authors: Yamada, S; Fujii, T; Yamamoto, T; Takami, H; Yoshioka, I; Yamaki, S; Sonohara, F; Shibuya, K; Motoi, F; Hirano, S; Murakami, Y; Inoue, H; Hayashi, M; Murotani, K; Kitayama, J; Ishikawa, H; Kodera, Y; Sekimoto, M; Satoi, S Journal: British journal of surgery Issue: Volume 107:Issue 13(2020) Page Start: 1811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗